EXTON, Pa., Feb. 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February 7, 2012 at Parc 55 in San Francisco, California.
Joseph W. Kaufmann, Kensey Nash‘s President and CEO, will deliver the Company’s presentation, beginning approximately at 10:40 a.m. (PT). The presentation materials will be available on the company’s website (www.kenseynash.com) beginning at 10:40 a.m. (PT) on Tuesday, February 7, 2012. The Canaccord Genuity Musculoskeletal Conference will be available by webcast. To listen to the webcast, go to http://event.on24.com/r.htm?e=396242&s=1&k=312B05B671DBD80BD74903D373C807ED.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.
SOURCE Kensey Nash Corporation
